A Multicenter Phase II Trial of Ramucirumab Plus Irinotecan in Patients with Early Relapsed Gastric Cancer During or After Adjuvant Docetaxel Plus S-1 Therapy: RAMIEL Trial (OGSG1901)

Atsushi Takeno, Toshifumi Yamaguchi, Yusuke Akamaru, Hidekazu Hirano, Masaaki Motoori, Yoshihiro Kakeji, Yosuke Kito, Takashi Nomura, Takeshi Kawakami, Masahiro Tanemura, Hiroyuki Okuda, Tomohiro Matsushima, Toshio Shimokawa, Yukinori Kurokawa, Shunji Endo, Narikazu Boku and Taroh Satoh

ASCO-GI 2026, San Francisco, California, United States 8-10 Jan2026

Warning: Trying to access array offset on false in /home/grwdev/grwdev.works/public_html/ogsg2026.grwdev.works/wp/wp-content/themes/OGSG/single.php on line 62